Prevalence of Endogenous Hypercortisolism in Individuals With Resistant Hypertension Stratified by Kidney Function: Results From the MOMENTUM Study
Monday, June 22, 2026 1 min read
Key Takeaway: The MOMENTUM study, presented at the 10th Annual Heart in Diabetes CME Conference, explores the prevalence of endogenous hypercortisolism in individuals with resistant hypertension, stratified by kidney function. The findings aim to enhance understanding of this condition and its implications for treatment. The presentation was made by Dr. Ralph A. DeFronzo.
Price reaction · baseline $78.135 (2026-06-22T16:29:00.000Z) · hit during market hours · clean, no other CORT news in the window
day 0 close · peak
+2%
Market Sentiment Analysis
POSITIVE FACTORS
The study presents new findings on hypercortisolism.
The research is being showcased at a reputable conference.
It addresses a significant health issue: resistant hypertension.
Full Press Release Details
Presented : 10th Annual Heart in Diabetes CME Conference, 19 June 2026, Philadelphia, PA
Presenter : Ralph A. DeFronzo, MD
Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.
Download Poster Download Presentation
The post Prevalence of Endogenous Hypercortisolism in Individuals With Resistant Hypertension Stratified by Kidney Function: Results From the MOMENTUM Study appeared first on Corcept Therapeutics .
Frequently Asked Questions
What is the MOMENTUM study about?
The MOMENTUM study investigates the prevalence of endogenous hypercortisolism in individuals with resistant hypertension.
Who presented the MOMENTUM study?
The study was presented by Dr. Ralph A. DeFronzo at a CME conference.
Where was the MOMENTUM study presented?
It was presented at the 10th Annual Heart in Diabetes CME Conference in Philadelphia.
What is the significance of the MOMENTUM study?
The study aims to improve understanding of hypercortisolism's impact on resistant hypertension.